Worsening of rosacea in patients treated with dihydropyridine calcium channel blockers: A clinical observation

Hypertension Research

Volumn 34, Issue 6, 2011, Pages 790-791

  Natale, Francesco ^a   Cirillo, Chiara ^a   Granato, Chiara ^a   Concilio, Claudia ^a   Siciliano, Alessandro ^a   Credendino, Maria ^a   Aronne, Luigi ^a   Calabrò, Paolo ^a   Russo, Maria G ^a   Calabrò, Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; RAMIPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; FEMALE; HOT FLUSH; HUMAN; LETTER; MALE; PERIPHERAL EDEMA; ROSACEA; TACHYCARDIA;

AMLODIPINE; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; ROSACEA;

EID: 79958153342     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.32     Document Type: Letter

References (3)

1. Culp B, Scheinfeld N. Rosacea: a Review. P T 2009; 34: 38-45.
2. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 1995; 130: 572-579.
3. Benson J, Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ 2002; 325: 873-877.